Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.
about
Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countriesClinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literatureFrom prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.What explains the differences between centres in the European screening trial? A simulation study.
P2860
Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Longitudinal changes of benign ...... community-based sample of men.
@ast
Longitudinal changes of benign ...... community-based sample of men.
@en
type
label
Longitudinal changes of benign ...... community-based sample of men.
@ast
Longitudinal changes of benign ...... community-based sample of men.
@en
prefLabel
Longitudinal changes of benign ...... community-based sample of men.
@ast
Longitudinal changes of benign ...... community-based sample of men.
@en
P2093
P2860
P1433
P1476
Longitudinal changes of benign ...... community-based sample of men.
@en
P2093
Cynthia J Girman
Debra J Jacobson
George G Klee
Jennifer L St Sauver
Kitaw Demissie
Michael M Lieber
Michaela E McGree
Thomas Rhodes
P2860
P304
P356
10.1016/J.UROLOGY.2011.09.056
P407
P577
2012-03-01T00:00:00Z